Position in DNLI
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,322,625
+$345,345 QoQ
Shares Held
51,424
+1.0% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#115
of 290 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. DNLI ranks #53 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in DNLI
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,322,625 | 51,424 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $977,280 | 50,900 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $638,425 | 38,669 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $470,665 | 32,415 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $469,196 | 33,538 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $427,290 | 31,430 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $766,736 | 37,622 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $815,028 | 27,979 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $490,894 | 21,141 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $457,513 | 22,296 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $505,619 | 23,561 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $476,986 | 23,121 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $461,034 | 15,623 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $954,708 | 41,437 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,137,901 | 40,917 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $1,274,126 | 41,516 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $895,937 | 30,443 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,073,126 | 33,358 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,273,909 | 28,563 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,324,362 | 26,251 | Shares | Sole | 2021-10-07 | |
| No filing history on record for this holder in this stock. | ||||||